GlassScriptPhysician profile
Simon A Holoubek
NPI 1043697618
$55,418.76
in general payments reported to CMS, 2019-2025
7 companies · $39K in 2025
The $39K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,291 · 2021: $135 · 2022: $251 · 2023: $234 · 2024: $13K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $41K · Travel and Lodging: $11K · Food and Beverage: $1,283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $40,635.00 |
| Travel and Lodging | $10,823.79 |
| Food and Beverage | $1,283.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $52,642.19 | 2022-2025 | Pteye Parathyroid Detection System, Nim Vital, Nim-Response |
| Allergan, INC. | $1,345.29 | 2019 | |
| Intuitive Surgical, INC. | $945.26 | 2019 | |
| Becton, Dickinson and Company | $195.82 | 2023 | Phasix Mesh |
| Ambu INC. | $135.33 | 2021 | |
| Davol INC. | $116.71 | 2022 | |
| Integra Lifesciences Corporation | $38.16 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Holoubek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.